do people gain weight back after semaglutide Regain Stopping Does stopping GLP-1s make you

Wegovy (semaglutide) is a once-a-week injection thats approved by the Food and Drug Administration (FDA) to: Reduce excess body weight and maintain weight reduction in: Adults with a body mass index (BMI) of 30 or higher Adults with a BMI of 27 or higher who also have weight-related medical problems, such as high cholesterol or high blood pressure Adolescents ages 1217 who are at or above the 95th percentile on sex- and age-specific growth charts Reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and a BMI of 27 or higher Wegovy belongs to a family of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists)

These medications are most effective for patients who: They are not designed for cosmetic or short-term weight loss

Skipping it isn't just a missed nutritional opportunity it may actually reduce the hormonal response your medication is trying to support

Hims & Hers Hims & Hers expanded from its original focus on mens and womens health into a broader weight loss program built around GLP-1 access

Months 3 to 6 and beyond Long-term semaglutide users generally report that GI symptoms, including reflux, stabilize or resolve entirely